Jefferies Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.9M Buy
193,340
+138,454
+252% +$66.5M 0.64% 18
2026
Q1
$27M Buy
54,886
+53,436
+3,685% +$29M 0.18% 87
2025
Q4
$840K Buy
1,450
+598
+70% +$338K ﹤0.01% 1153
2025
Q3
$413K Sell
852
-1,312
-61% -$611K ﹤0.01% 1134
2025
Q2
$877K Sell
2,164
-14,210
-87% -$5.94M 0.01% 771
2025
Q1
$8.15M Buy
16,374
+5,632
+52% +$3.05M 0.07% 189
2024
Q4
$5.59M Sell
10,742
-2,089
-16% -$1.15M 0.03% 338
2024
Q3
$7.94M Sell
12,831
-2,777
-18% -$1.64M 0.06% 218
2024
Q2
$8.63M Buy
15,608
+4,567
+41% +$2.62M 0.09% 179
2024
Q1
$6.42M Sell
11,041
-19,289
-64% -$10.8M 0.06% 251
2023
Q4
$16.1M Buy
30,330
+21,747
+253% +$10.5M 0.11% 139
2023
Q3
$4.34M Sell
8,583
-8,566
-50% -$4.56M 0.04% 379
2023
Q2
$8.95M Buy
17,149
+11,807
+221% +$6.37M 0.08% 227
2023
Q1
$3.08M Sell
5,342
-81,809
-94% -$46.1M 0.02% 518
2022
Q4
$48M Buy
+87,151
New +$46.2M 0.33% 43

Other funds holding TMO

Jefferies Financial Group's TMO Position: Q2 2026 in Review

Jefferies Financial Group increased its Thermo Fisher Scientific (TMO) stake by 252% in Q2 2026, buying an estimated $66.5M and bringing the position to 193,340 shares worth $96.9M. The position accounts for 0.64% of the portfolio, ranked #18.

Jefferies Financial Group first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Jefferies Financial Group held 193,340 shares of Thermo Fisher Scientific worth $96.9M as of Q2 2026.
  • Jefferies Financial Group bought 138,454 Thermo Fisher Scientific shares in Q2 2026, an estimated $66.5M.
  • Thermo Fisher Scientific made up 0.64% of Jefferies Financial Group's portfolio in Q2 2026, its #18 holding.
  • Jefferies Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • 2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.